anti-Diethylstilbestrol (p-OH)-KLH antibody product blog
Tags: Antibody; Polyclonal Antibody; Diethylstilbestrol (p-OH)-KLH; anti-Diethylstilbestrol (p-OH)-KLH antibody;
The Diethylstilbestrol n/a (Catalog #MBS340118) is an Antibody produced from Sheep and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Diethylstilbestrol can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Dot Blot (DB), Immunohistochemistry (IHC), Immunoassays, Development of Rapid tests and Other Immunoassay, Antibody Recognition Assays. Researchers should empirically determine the suitability of the Diethylstilbestrol n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The stilbene derivatives diethylstilbestrol (DES), dienestrol and hexestrol are synthetic oestrogens that have been demonstrated to be genotoxic and carcinogenic in both animals and humans. DES has been used commercially as a growth-promoting agent in livestock, as a human medication to help maintain pregnancy and in the treatment of prostate cancer in humans, but was removed from these uses due to human carcinogenicity issues. DES, dienestrol and hexestrol are excreted in urine primarily as glucuronide tracer.
Immunogen: DES(p-OH)-KLH. Buffer: 20mM Phosphate, 150mM Sodium Chloride
Preservative: 0.09% Sodium Azide. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Diethylstilbestrol are readily searchable from our website. Different antibodies against the same target such as Diethylstilbestrol may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.